MedPath
NMPA Approval

Diquafosol Sodium Eye Drops

国药准字H20243571

April 24, 2024

Drug Information

地夸磷索钠滴眼液

眼用制剂

3%(5ml:150mg)

化学药品

April 24, 2024

Company Information

Applicant Company

湖北省武汉市经济技术开发区高新技术工业园28号

Manufacturing Company

湖北省武汉市经济技术开发区高新技术工业园28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地夸磷索钠滴眼液 - NMPA 批准文号 | MedPath